Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare ...

Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration ...

Unilever shocked the market when it announced its chief exec Hein Schumacher would be replaced by finance chief Fernando ...

Thermo Fisher’s release goes on to suggest that it believes it can more than double the profitability of Purification & Filtration under its corporate umbrella, relative to the business’ current ...

In today’s CEO Daily: Peter Vanham on activist investor Nelson Peltz and ... to CEO Daily on Wednesday, Peltz made a clear endorsement of the new CEO: “Trian believes continued operational ...

M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.

In this case, that comes in the form of CEO Iger's own personal antagonist, activist investor Nelson Peltz. Peltz, who runs hedge fund Trian Fund Management, has been upping his stake in Disney ...

Unilever's board, which includes billionaire activist investor Nelson Peltz, was unified in its decision to oust CEO Hein ...

Feb 26 (Reuters) - Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum (SOLV.N), opens new tab for further business separations following the company's $4.1 billion ...

Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in April 2024.